Generic competition · all medicines · read 12 November 2026

Is there a generic of Fentanyl Citrate, and who makes it?

Fentanyl Citrate appears in 8 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 1 generic maker listed as marketed across them. Where both are dated, the first generic approval came between 4.3 and 11 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Method designed and maintained by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). Data compiled automatically from the Orange Book data files, downloaded 12 November 2026. How these pages are made

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Fentanyl Citrate8 dosage-form groups in the Orange Book
1generic maker listed
  1. Fentanyl Citrate appears in 8 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 1 generic maker listed as marketed across them.
  2. Where both are dated, the first generic approval came between 4.3 and 11 years after the first brand approval.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Troche/Lozenge, Transmucosal

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed (12 generic products listed as discontinued).

1995200020052010201520202025203001brand 1998data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Tablet, Buccal, Sublingual

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed (11 generic products listed as discontinued).

20052010201520202025203001brand 2006data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Tablet, Sublingual

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed (6 generic products listed as discontinued).

2010201520202025203001brand 2011data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Injectable, Injection

One to three generic makers listed

Brand listed as marketed: Fentanyl Citrate and Sublimaze Preservative Free. 1 generic maker with 2 generic products listed as marketed; the first generic approval is dated 30 April 1990.

1980198519901995200020052010201520202025203001brand 1984Fresenius Kabi Usa Llc, first approval 3 May 2019data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Fresenius Kabi Usa Llc3 May 20192

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Film, Buccal

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

20052010201520202025203001brand 2009data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Troche/Lozenge, Oral

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

19901995200020052010201520202025203001brand 1993data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Spray, Metered, Nasal

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

2010201520202025203001brand 2011data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Intravenous

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

20202025203001brand 2023data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

What do pharmacies pay for Fentanyl Citrate?

The CMS NADAC survey tracks what pharmacies pay to acquire Fentanyl Citrate: 14 products with year-end prices from 2013 to 2026. See the acquisition cost history on RxGrab. It is a pharmacy cost, not a retail price, and this page does not say how it relates to the number of makers listed above.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.